Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for Oruka Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-27 6:43 pm Purchase |
2025-02-10 | 13G | Oruka Therapeutics, Inc. ORKA |
Venrock Healthcare Capital Partners III L.P. | 4,148,428 11.100% |
606,487 (+17.12%) |
Filing |
| 2024-11-14 5:49 pm Purchase |
2024-09-30 | 13G | Oruka Therapeutics, Inc. ORKA |
Venrock Healthcare Capital Partners III L.P. | 3,541,941 9.990% |
3,541,941 (New Position) |
Filing |